Pharmaceutical manufacturing

FILE- This June 25, 2018 file photo shows the New York Stock Exchange in New York. Stocks are opening broadly higher on Wall Street, Tuesday, July 31, 2018, as technology companies rise after a three-day losing streak. Industrial companies were also higher (AP Photo/Seth Wenig, File)
July 31, 2018 - 4:41 pm
NEW YORK (AP) — U.S. stocks rose Tuesday following strong results from industrial and health care companies as well as a report that the U.S. and China are trying to restart trade talks. Small companies rallied. Bloomberg News reported that representatives of the U.S. and China are looking for ways...
Read More
FILE - In this Nov. 23, 2015, file photo, the Pfizer logo is displayed at world headquarters in New York. Pfizer Inc. (PFE) on Tuesday, July 31, 2018, reported second-quarter earnings of $3.87 billion. (AP Photo/Mark Lennihan, File)
July 31, 2018 - 7:57 am
Pfizer's second-quarter profit surged 26 percent, thanks to a 4 percent increase in medicine sales, higher income from partnerships and lower tax expenses. The biggest U.S.-based drugmaker on Tuesday beat Wall Street expectations and boosted its 2018 profit forecast. However, Pfizer trimmed its...
Read More
FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. on Friday, July 27 reported second-quarter profit of $1.71 billion. The Kenilworth, New Jersey-based company said it had profit of 63 cents per share. Earnings, adjusted for costs related to mergers and acquisitions and restructuring costs, were $1.06 per share. (AP Photo/Seth Wenig, File)
July 27, 2018 - 10:34 am
Soaring sales of cancer drugs, vaccines and veterinary medicines drove Merck & Co.'s 5 percent jump in second-quarter revenue and the company lifted its outlook for the year. Long known for primary care with its allergy, cholesterol, diabetes, heart and osteoporosis medications and shots to...
Read More
July 25, 2018 - 7:17 am
LONDON (AP) — Drug maker GlaxoSmithKline says second-quarter revenue was 7.3 billion pounds ($9.6 billion), up 4 percent when discounting currency shifts, amid a promising performance of a new shingles treatment. Sales of the shingles treatment Shingrix made 167 million pounds, and the company...
Read More

Pages